Identification of a thalidomide derivative that selectively targets tumorigenic liver progenitor cells and comparing its effects with lenalidomide and sorafenib.
Woo K, Stewart SG, Kong GS, Finch-Edmondson ML, Dwyer BJ, Yeung SY, Abraham LJ, Kampmann SS, Diepeveen LA, Passman AM, Elsegood CL, Tirnitz-Parker JE, Callus BA, Olynyk JK, Yeoh GC.
Woo K, et al. Among authors: abraham lj.
Eur J Med Chem. 2016 Sep 14;120:275-83. doi: 10.1016/j.ejmech.2016.03.015. Epub 2016 Mar 9.
Eur J Med Chem. 2016.
PMID: 27208658
Free article.